ARTICLE | Company News
Ligand sales and marketing update
April 24, 1995 7:00 AM UTC
Ligand Pharmaceuticals Inc. (LGND) LGND began Canadian sales of Proleukin interleukin-2 to treat metastatic kidney cancer. The San Diego company's Canadian subsidiary, Ligand Pharmaceuticals (Canada)...